US Stock MarketDetailed Quotes

Petros Pharmaceuticals (PTPI)

Watchlist
  • 0.0085
  • +0.0000+0.30%
15min DelayClose Jan 15 14:48 ET
358.05KMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Petros Pharmaceuticals (PTPI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
-12.20%5.11M
1,503.44%5.11M
0
0
0
-2.83%5.82M
-145.64%-364.25K
Operating revenue
--0
--0
--0
-12.20%5.11M
1,503.44%5.11M
--0
--0
--0
-2.83%5.82M
-145.64%-364.25K
Cost of revenue
-25.66%1.21M
67.41%264.75K
-29.74%287.01K
-35.95%329.11K
-39.75%331.83K
-28.75%1.63M
-82.06%158.15K
Gross profit
-6.96%3.9M
188.18%460.65K
1.83%1.29M
-26.20%1.09M
-46.27%1.06M
13.19%4.19M
-527.65%-522.4K
Operating expense
-17.26%990.74K
33.48%1.8M
-2.97%1.46M
-5.07%14.2M
124.66%10.15M
-62.79%1.2M
-65.78%1.35M
-54.13%1.5M
-23.50%14.95M
12.40%4.52M
Selling and administrative expenses
-17.26%990.74K
33.48%1.8M
-2.97%1.46M
-5.53%8.75M
63.22%4.7M
-40.19%1.2M
-40.03%1.35M
-29.46%1.5M
-24.14%9.26M
-1.52%2.88M
Research and development costs
----
----
----
8.55%2.62M
-87.78%101.95K
51.21%588.36K
-57.44%368.8K
387.62%1.56M
38.43%2.41M
369.35%834.33K
Depreciation amortization depletion
----
----
----
-13.76%2.83M
-18.25%656.09K
-10.56%739.45K
-13.18%717.84K
-13.18%717.84K
-41.36%3.28M
-12.41%802.58K
-Depreciation and amortization
----
----
----
-13.76%2.83M
-18.25%656.09K
-10.56%739.45K
-13.18%717.84K
-13.18%717.84K
-41.36%3.28M
-12.41%802.58K
Operating profit
17.26%-990.74K
-33.48%-1.8M
2.97%-1.46M
4.33%-10.3M
-23.98%-6.25M
38.65%-1.2M
45.22%-1.35M
-14.79%-1.5M
32.08%-10.76M
-22.86%-5.04M
Net non-operating interest income expense
-11.61%67.01K
-25.58%88.85K
-68.52%47.79K
-808.15%-189.14K
-626.85%-536.17K
104.20%75.82K
242.34%119.39K
300.16%151.82K
96.42%-20.83K
177.83%101.77K
Non-operating interest income
-11.61%67.01K
-25.58%88.85K
-68.52%47.79K
-27.86%371.77K
-89.13%24.74K
-55.00%75.82K
125.59%119.39K
128.93%151.82K
3,530.48%515.31K
1,503.42%227.59K
Non-operating interest expense
----
----
----
4.62%560.91K
33.09%167.46K
20.84%158.73K
-16.29%114.51K
-15.45%120.21K
-10.05%536.14K
-13.19%125.82K
Other net income (expense)
-99.50%1K
-120.41%-329.34K
-87.83%211.02K
-246.32%-3.83M
-240.51%-7.38M
107.67%202K
1.61M
1.73M
172.58%2.62M
5.26M
Gain on sale of security
-99.50%1K
-120.41%-329.34K
-87.83%211.02K
-74.10%3.55M
--0
-97.61%202K
--1.61M
--1.73M
2,880.22%13.71M
--5.26M
Special income (charges)
----
----
----
---7.38M
----
----
----
----
--0
----
-Less:Impairment of capital assets
----
----
----
--7.38M
----
----
----
----
--0
----
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
-427.11%-11.09M
--0
Income before tax
-0.35%-922.72K
-631.18%-2.04M
-413.28%-1.2M
-75.41%-14.32M
-4,552.75%-14.17M
79.79%-919.54K
115.09%384.29K
127.64%382.89K
59.26%-8.16M
107.52%318.15K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
58.45%-922.72K
920.64%5.43M
-4.50%-2.26M
-75.41%-14.32M
-3,014.80%-9.27M
51.19%-2.22M
74.00%-662.03K
-56.13%-2.16M
59.26%-8.16M
107.54%318.15K
Net income continuous Operations
-0.35%-922.72K
-631.18%-2.04M
-413.28%-1.2M
-75.41%-14.32M
-4,552.75%-14.17M
79.79%-919.54K
115.09%384.29K
127.64%382.89K
59.26%-8.16M
107.54%318.15K
Net income discontinuous operations
--0
147.86%500.82K
58.34%-1.06M
----
----
---1.3M
---1.05M
---2.55M
----
----
Net income extraordinary
--0
--6.97M
----
----
----
--0
--0
----
----
----
Minority interest income
Net income attributable to the parent company
58.45%-922.72K
920.64%5.43M
-4.50%-2.26M
-75.41%-14.32M
-3,014.80%-9.27M
51.19%-2.22M
74.00%-662.03K
-56.13%-2.16M
59.26%-8.16M
107.54%318.15K
Preferred stock dividends
-78.02%231.21K
0.64%218.19K
-53.79%275.17K
180.98%2.31M
-7.90%444.12K
210.02%1.05M
216.8K
595.51K
821.46K
482.22K
Other preferred stock dividends
0
1,983.35%38.67M
58.59%8.36M
110.57%10.17M
-70.86%1.07M
71.11%1.97M
1.86M
5.27M
4.83M
3.68M
Net income attributable to common stockholders
78.01%-1.15M
-1,123.23%-33.45M
-35.68%-10.89M
-93.98%-26.8M
-180.95%-10.79M
13.17%-5.25M
-7.39%-2.73M
-479.50%-8.03M
31.06%-13.81M
9.03%-3.84M
Basic earnings per share
99.99%-0.0012
86.05%-1.29
77.79%-9.37
47.40%-83.5
69.80%-12.23
76.63%-16.65
69.17%-9.25
-155.70%-42.19
34.40%-158.75
20.20%-40.5
Diluted earnings per share
99.99%-0.0012
86.05%-1.29
77.79%-9.37
47.40%-83.5
69.80%-12.23
76.63%-16.65
69.17%-9.25
-155.70%-42.19
34.40%-158.75
20.20%-40.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 000-12.20%5.11M1,503.44%5.11M000-2.83%5.82M-145.64%-364.25K
Operating revenue --0--0--0-12.20%5.11M1,503.44%5.11M--0--0--0-2.83%5.82M-145.64%-364.25K
Cost of revenue -25.66%1.21M67.41%264.75K-29.74%287.01K-35.95%329.11K-39.75%331.83K-28.75%1.63M-82.06%158.15K
Gross profit -6.96%3.9M188.18%460.65K1.83%1.29M-26.20%1.09M-46.27%1.06M13.19%4.19M-527.65%-522.4K
Operating expense -17.26%990.74K33.48%1.8M-2.97%1.46M-5.07%14.2M124.66%10.15M-62.79%1.2M-65.78%1.35M-54.13%1.5M-23.50%14.95M12.40%4.52M
Selling and administrative expenses -17.26%990.74K33.48%1.8M-2.97%1.46M-5.53%8.75M63.22%4.7M-40.19%1.2M-40.03%1.35M-29.46%1.5M-24.14%9.26M-1.52%2.88M
Research and development costs ------------8.55%2.62M-87.78%101.95K51.21%588.36K-57.44%368.8K387.62%1.56M38.43%2.41M369.35%834.33K
Depreciation amortization depletion -------------13.76%2.83M-18.25%656.09K-10.56%739.45K-13.18%717.84K-13.18%717.84K-41.36%3.28M-12.41%802.58K
-Depreciation and amortization -------------13.76%2.83M-18.25%656.09K-10.56%739.45K-13.18%717.84K-13.18%717.84K-41.36%3.28M-12.41%802.58K
Operating profit 17.26%-990.74K-33.48%-1.8M2.97%-1.46M4.33%-10.3M-23.98%-6.25M38.65%-1.2M45.22%-1.35M-14.79%-1.5M32.08%-10.76M-22.86%-5.04M
Net non-operating interest income expense -11.61%67.01K-25.58%88.85K-68.52%47.79K-808.15%-189.14K-626.85%-536.17K104.20%75.82K242.34%119.39K300.16%151.82K96.42%-20.83K177.83%101.77K
Non-operating interest income -11.61%67.01K-25.58%88.85K-68.52%47.79K-27.86%371.77K-89.13%24.74K-55.00%75.82K125.59%119.39K128.93%151.82K3,530.48%515.31K1,503.42%227.59K
Non-operating interest expense ------------4.62%560.91K33.09%167.46K20.84%158.73K-16.29%114.51K-15.45%120.21K-10.05%536.14K-13.19%125.82K
Other net income (expense) -99.50%1K-120.41%-329.34K-87.83%211.02K-246.32%-3.83M-240.51%-7.38M107.67%202K1.61M1.73M172.58%2.62M5.26M
Gain on sale of security -99.50%1K-120.41%-329.34K-87.83%211.02K-74.10%3.55M--0-97.61%202K--1.61M--1.73M2,880.22%13.71M--5.26M
Special income (charges) ---------------7.38M------------------0----
-Less:Impairment of capital assets --------------7.38M------------------0----
Other non- operating income (expenses) ---------------------------------427.11%-11.09M--0
Income before tax -0.35%-922.72K-631.18%-2.04M-413.28%-1.2M-75.41%-14.32M-4,552.75%-14.17M79.79%-919.54K115.09%384.29K127.64%382.89K59.26%-8.16M107.52%318.15K
Income tax 0000000000
Net income 58.45%-922.72K920.64%5.43M-4.50%-2.26M-75.41%-14.32M-3,014.80%-9.27M51.19%-2.22M74.00%-662.03K-56.13%-2.16M59.26%-8.16M107.54%318.15K
Net income continuous Operations -0.35%-922.72K-631.18%-2.04M-413.28%-1.2M-75.41%-14.32M-4,552.75%-14.17M79.79%-919.54K115.09%384.29K127.64%382.89K59.26%-8.16M107.54%318.15K
Net income discontinuous operations --0147.86%500.82K58.34%-1.06M-----------1.3M---1.05M---2.55M--------
Net income extraordinary --0--6.97M--------------0--0------------
Minority interest income
Net income attributable to the parent company 58.45%-922.72K920.64%5.43M-4.50%-2.26M-75.41%-14.32M-3,014.80%-9.27M51.19%-2.22M74.00%-662.03K-56.13%-2.16M59.26%-8.16M107.54%318.15K
Preferred stock dividends -78.02%231.21K0.64%218.19K-53.79%275.17K180.98%2.31M-7.90%444.12K210.02%1.05M216.8K595.51K821.46K482.22K
Other preferred stock dividends 01,983.35%38.67M58.59%8.36M110.57%10.17M-70.86%1.07M71.11%1.97M1.86M5.27M4.83M3.68M
Net income attributable to common stockholders 78.01%-1.15M-1,123.23%-33.45M-35.68%-10.89M-93.98%-26.8M-180.95%-10.79M13.17%-5.25M-7.39%-2.73M-479.50%-8.03M31.06%-13.81M9.03%-3.84M
Basic earnings per share 99.99%-0.001286.05%-1.2977.79%-9.3747.40%-83.569.80%-12.2376.63%-16.6569.17%-9.25-155.70%-42.1934.40%-158.7520.20%-40.5
Diluted earnings per share 99.99%-0.001286.05%-1.2977.79%-9.3747.40%-83.569.80%-12.2376.63%-16.6569.17%-9.25-155.70%-42.1934.40%-158.7520.20%-40.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -